Summary How have computational protocols advanced in the last few years to make quantifiable impact in projects for small molecules in drug design?
Join us, for a 1-hour seminar and we will share a birds-eye view of how state-of-the-art science is being used routinely to alleviate challenging design questions and enabling ideation across different teams. This is with a view to achieving one critical goal - speeding up drug discovery cycles.
We will discuss small molecule design case studies, in context of the Schrödinger Modelling Platform with the view to knowledge transfer, offering modelling services or adoption of any modelling tools that you require to make your business model more effective.
